Free beta access. 50 free AI tokens each week. Optional top-ups available. See what is included
Open evidence library

Search the archive.

Current and older evidence is free during beta. Sign in for unlimited card access and full source downloads.

Matching cards
2022 Michigan Negative
Disad things › DA/Turn - China Biotech Good › --xt Chinese Regs Better

China has better regs than the US

Chin 21 [ Michael Chin, 2-10-2021, “China’s New PRC Biosecurity Law”, Simmons & Simmons, , accessed 6-28-2022]

Against the background of the outbreak of COVID-19, the Standing Committee of the PRC National People's Congress fast tracked the passing of the PRC Biosecurity Law ("Biosecurity Law") on 17 October 2020 with the law to take effect on 15 April 2021.

The Biosecurity Law seeks to cover a wide range of areas under a broad definition of "biosecurity" and in doing so brings together an existing piece meal set of regulations in the following areas: epidemic control of infectious diseases for humans, quarantines for animals and plants; research, development, and application of biology technology; establishment and security of pathological microorganism labs; administration of human genetic resources and biological resources; and prevention of bioterrorism and defending threats of biological weapons.

2022 Michigan Negative
Disad things › DA/Turn - China Biotech Good › --xt Chinese Regs Better

China already has regs

Araz 20 [Sevan Araz, research intern with the Technology Policy Program at the Center for Strategic and International Studies in Washington, DC., 8-31-2020, “China Adopts Biotechnology Regulation, Amid Authoritarianism Concerns”, Center for Strategic and International Studies, https://www.csis.org/blogs/technology-policy-blog/china-adopts-biotechnology-regulation-amid-authoritarianism-concerns, accessed 6-22-2022]

China is gearing up to become a biotechnology powerhouse. Within the past five years the Chinese government is estimated to have invested over $100 billion in life sciences research and development. Further signaling its determination, Beijing is lavishing the sector with a host of fiscal incentives while state-backed entities dish out largesse to promising startups.

As biotechnologies rapidly proliferate, China—and other states—are rushing to develop regulatory and ethical frameworks. The COVID-19 pandemic has raised the urgency of such efforts. To set parameters for the evolving sector, Beijing has rolled out various initiatives.

2022 Michigan Negative
Disad things › DA/Turn - China Biotech Good › --xt

China threat overhyped– their biotech industry has been creating and complying with international norms

Master 21 (Farah Master, “Analysis: China’s biotech sector comes of age with big licensing deals, global ambitions”, Reuters, September 16th 2021, , WC-NAS) HONG KONG, Sept 16 (Reuters) - If investors in China's biotech industry needed one more sign that the sector is coming of age, then a major licensing deal RemeGen Co Ltd  struck last month with Seattle-based Seagen Inc  fits the bill.

The agreement to co-develop cancer treatments using a RemeGen antibody drug conjugate is regarded as one of the biggest of its kind between a Chinese biotech and a Western firm. It provides for up to $2.4 billion in milestone payments, in addition to $200 million upfront as well as royalties if approved.

It is also at least the fifth out-licensing deal potentially worth more than $1 billion clinched by a Chinese biotech. Nearly all were signed in the past year, underscoring China's still small but growing role in developing innovative cancer drugs that will be used worldwide.

2022 Michigan Negative
Disad things › DA/Turn - China Biotech Good › 1NC – China Sets Standards

China creates effective biotech standards independent of US leadership– They’re creating ethical international norms now

Terry 22 (Mark Terry, “China Introduces Strict New Bioethics for Genetics Materials”, BioSpace, April 29th 2022, , WC-NAS)

China recently  new  for bioethics related to human genetic resources. Reportedly, these will “clarify jurisdictions of regulatory bodies and enhance supervision related to biopharmaceutical research.”

The country’s new proposed rules define human genetic resources, according to the Genetic Literacy Project, “as genetic materials, including organs, tissues and cells, as well as genetic information, such as the human genome and genes.”

2022 Michigan Negative
Disad things › DA/Turn - China Biotech Good › 1NC - AT: Bioethics

China threat in biotech ethics is overhyped; they aren’t a security threat

Moore and Coplin 22 (Scott Moore and Abigail Coplin, “Closing the U.S. to Chinese Biotech Would Do Far More Harm Than Good”, China File, April 8th 2022, , WC-NAS)

Just as security-driven approaches stand at odds with many realities of the biotechnology sector, U.S. policymakers and politicians sometimes mischaracterize and exoticize the threats that China’s growing global role in biotechnology pose to U.S. national security. These mischaracterizations often take the form of highlighting behavior that is hardly unique to China, and is, in fact, common in the industry. Fears  by some U.S. officials that Beijing is pursuing research in areas like human genetic enhancement for military purposes, for instance, are wildly exaggerated; such techniques lie  the realm of scientific feasibility. Moreover, while  between the People’s Liberation Army (PLA) and Chinese biotechnology companies and research institutes should be thoroughly investigated, not all military-funded medical research and dual-use technologies constitute security threats. For instance, the media has  BGI’s hearing loss research with the PLA, yet the American Department of Defense  multiple hearing loss projects at American academic and commercial medical institutions, in addition to countless other medical research projects on topics as uncontroversial as  cancer, , and . In both countries, many military-funded dual-use projects in the biological sciences consist of rather innocuous medical research, including .

Another dubious concern is the growing collection of biomedical data by Chinese firms operating abroad. Surreptitious collection of personal medical data was highlighted last summer both by Senator  and in a  finding that BGI Group, a leading Chinese genomics firm, was collecting data from millions of prenatal tests offered to pregnant women within and outside China. But the sort of collection undertaken by BGI, for instance, does not appear to be illegal, or even out-of-line with the practices of its foreign competitors. While BGI’s data collection efforts benefit from China’s more centralized healthcare provision system, using genetic diagnostic tests to build datasets is the main business model of both the  and the clinical genetics industry globally. In fact, BGI’s proclivity for academic research, , and international collaboration arguably renders some aspects of the organization’s data use more transparent than some of its international counterparts.

2022 Michigan Negative
Disad things › DA/Turn - China Biotech Good › 1NC – Innovation

Regulations are bad; even if positively intended, they lose us the tech race

Ezell 21 (Stephen Ezell, “Going, Going, Gone? To Stay Competitive in Biopharmaceuticals, America Must Learn From Its Semiconductor Mistakes”, Information Technology & Innovation Foundation, )

U.S. leadership in advanced-technology industries is never guaranteed. America once held dominant market shares in a long list of industries—including consumer electronics, machine tools and robotics, telecommunications equipment, and solar panels—only to see those leads significantly erode, and in some cases evaporate entirely. And because process and product innovation are so often joined at the hip, losing production capacity to overseas competitors often leads to loss of U.S. innovation capacity. Some contend it’s acceptable to cede leadership in innovation industries because America will just create new ones. But intensifying global competition, notably from China, now makes such indifference untenable.

America’s loss of semiconductor manufacturing capacity (which has fallen from 37 to 12 percent of global production over the past three decades) and its lag in cutting-edge chip development both are due in significant part to policy inattentiveness. This should serve as a warning for policymakers: Failing to maintain a policy environment that nurtures both innovation and domestic production capability risks sacrificing U.S. leadership in other advanced-technology industries, such as biopharmaceuticals.

2022 Michigan Negative
Disad things › DA/Turn - China Biotech Good › 1NC – Innovation

Competitive engagement with China over biotech stifles innovation

Moore and Coplin 22 (Scott Moore and Abigail Coplin, “Closing the U.S. to Chinese Biotech Would Do Far More Harm Than Good”, China File, April 8th 2022, , WC-NAS)

China is fast becoming a biotechnology powerhouse and a perceived threat to the longstanding dominance of the United States in the sector. In Washington, these developments have been greeted in much the same way as China’s growing prowess in artificial intelligence and other emerging technologies: with panic and punitive measures. Last May, Florida Republican Senator Marco Rubio introduced the , which would, among other actions, ban the National Institutes of Health from funding China-affiliated entities. In September, Arkansas Republican Senator Tom Cotton and Wisconsin Representative Mike Gallagher  for “” Chinese biotechnology companies over concerns they may be attempting to gather biomedical information on U.S. citizens for nefarious purposes. Just a few months later, the U.S. government  12 Chinese life sciences research institutes and 22 private firms on security grounds.

There is a big problem, however, with these largely reactive, security-focused responses. Biotechnology is an intrinsically transnational and rapidly evolving sector that holds just as much promise for mutually beneficial collaboration and cooperation as for competition and contention. These distinctive characteristics of biotechnology mean that Washington’s security-driven approach to China and biotechnology risks harming U.S. competitiveness in the sector instead of enhancing it, while also limiting America’s ability to share in the development of mutually-beneficial technologies and work with Beijing to address the shared challenges posed by rapid developments in fields like gene editing. U.S. policy and strategy on China and biotechnology must strike a better balance between addressing legitimate concerns while maintaining the openness and innovation that underpin America’s competitive advantage in emerging technology.

2022 Michigan Negative
Disad things › DA – GMOs › AT: Aff epistemology

Narratives of GMO effectiveness prop up the agribusiness industry – lock in low food and environmental standards, degrade soil, and hurt small farmers

Soil Association 20 British baised charity organization that campaigns against intensive farming and emphasized local production [“Stop Genetic Modification.” The Soil Association. Nov 2020]

Don’t believe the hype: New GM techniques In July 2018, the European Court of Justice ruled that new genetic editing techniques count as GM and must be properly regulated. We welcomed this move. These newer techniques, which include so-called ‘gene editing’, continue to be regulated as GM in the UK following Brexit. In 2019/20, the Government announced an aspiration to change this, particularly for new techniques which interfere with DNA, but do not insert genes from foreign species. But GM has a track record of failing to deliver. We are told that GM foods are needed to feed our growing population and to meet the challenges of climate change and pests, yet real world experience has shown that GM crops have not lived up to their promises. This booklet from Claire Robinson (Editor of GMWatch.org) and produced by the Sheepdrove Trust (pdf, 20mb) debunks the myths spread by the producers of GM products and the chemicals they rely on. These newer technologies, like ‘old GM’ are perfectly suited to distract from what is really needed, and to end up concentrating corporate control, putting big agribusiness firmly in the driving seat. We only have to look at the US and Brazil to see what direction GM takes us in - low food and environmental standards, farmers faced with degraded soils that are far from resilient to climate change, and wildlife in crisis. What are the risks of genetic modification? ‘This is a bottle that once opened, cannot be closed. To check the contents first, mistakes and all, is just scientific common sense’. All GM techniques, new and old, should remain subject to risk assessment, traceability and labelling to ensure farmer choice, consumer choice and the safeguarding of health & environment. Regulation is needed not only for novel traits, but also for the process of DNA interference itself. DNA interference is something all GM techniques do, including gene editing. It raises a great deal of scientific uncertainty. Recent research has raised more questions than answers, highlighting unexpected effects in all editing techniques, in the form of DNA errors and changes in gene expression. The repercussions are not well understood. Newer ‘gene editing’ techniques raise another level of uncertainty given their completely novel ability to do a large number of different edits, allowing changes to quickly accumulate. Organic food and farming Organic standards adopt a precautionary approach to new technologies and prohibit GM. The organic sector must be given the possibility and capacity to remain GMO-free. To protect the income and livelihoods of organic farmers and processors, all contamination of non-GMO materials should be prevented by the GMO producer in line with the polluter pays principle.

2022 Michigan Negative
Disad things › DA – GMOs › AT: Safe

They won’t be developed safety – the EU lacks a regulatory framework.

CEO 2021 - Corporate Europe Observatory has been tracking the industry’s lobby attempts to get new GM techniques deregulated since 2015 ["Derailing EU rules on new GMOs," Mar 29, https://corporateeurope.org/en/2021/03/derailing-eu-rules-new-gmos]

The January 2020 report’s conclusions show that a quick fix-approach to deregulate genome editing products is seen as necessary – “to be competitive globally”– but not enough. At least some of the participants aim for “a long-term paradigm shift” towards legislation that is product-based. This would mean that GMOs would only be assessed looking at their new trait, not taking into account the process (ie the technique) by which they were created. Sidenote

Officials were told that if GM regulations were lifted, “other regulations exist that will still ensure safety”. However, these other regulations (such as plant variety registration) do not assess food safety and environmental aspects as the GM risk assessment does, according to this analysis commissioned by the German Federal Agency for Nature Conservation.

2022 Michigan Negative
Disad things › DA – GMOs › AT: Feeds the Hungry

Gmos don’t solve hunger

Green America No Date[“GMOs Don’t Feed the World”, Green America, ., accessed 6-28-2022]

The vast majority of GMO crop production does not go towards direct food consumption; rather, it is used for the production of animal feed and ethanol. These are crops engineered to withstand, work in partnership with, and self-generate pesticides. They are not engineered to increase yield or face climate-related challenges to growth, such as drought tolerance. There is one variety of corn has been bred for drought resistance, but it is likely to only be effective in 15 percent of US corn fields and is not effective in severe or extreme drought, which we are expected to have more of in the coming years.

Industrial agriculture isn't the answer.

2022 Michigan Negative
Disad things › DA – GMOs › Impact - Food

Food security and soil security are intrinsically linked – decimation of soil has cascading effects for global food supply

Pozza and Field 20 – Research Associate at the the University of Sydney Institute of Agriculture and School of Life and Environmental Sciences; Professor of Global Soil Security & Soil Science Education at the Unviersity of Sydeny [Liana E.; Damien, J. “The Science of Soil Secuirty and Food Security” ScienceDirect. 11/11/2020.]

Food and Nutrition Security are intrinsically linked to the soil. Trying to accommodate growing food demand through unsustainable intensification and management practices is degrading the soil and we are running out of . To avoid further degradation, land needs to be used based upon what it can do. We need to care for the soil and take measures to maintain its capability and condition, or work to restore what has been lost through regenerative agriculture. The way people connect to the soil influences management decisions and consumer choices. Education helps people connect and understand their impact upon the soil, while policy and governance ensures continued protection, regeneration, and sustainable management of the soil. Obtaining Food Security is difficult if we do not have healthy soils to support production. In urban areas we are less connected to the soil but are still heavily reliant upon it. Subsistence farmers, who possess a more direct connection to the soil are most sensitive to poor soil condition. In terms of utilisation, our nutrition and health come from the soil – if the soil in which our produce is grown lacks the micronutrients we need, such as Zinc and Copper, then we will be deficient.

The dimensions of Soil Security are well-defined, but require further thought and research on potential indicators of connectivity. In contrast, the dimensions of Food Security have clear definitions, but they are harder to assess, so development of more consistent assessment is needed, or potentially a way to use Soil Security as a proxy measure in the meantime.

2022 Michigan Negative
Disad things › DA – GMOs › Impact - Food

Soil destruction decimates food security – lowers production, raises prices, and causes cascading insecurity

Pozza and Field 20 – Research Associate at the the University of Sydney Institute of Agriculture and School of Life and Environmental Sciences; Professor of Global Soil Security & Soil Science Education at the Unviersity of Sydeny [Liana E.; Damien, J. “The Science of Soil Secuirty and Food Security” ScienceDirect. 11/11/2020.]

Without secure soil, nutritious food will be much harder to produce into the foreseeable future, and how we access food influences the relationship individuals and communities have with the soil. To visually demonstrate this, it is possible to map the relationship between Food and Nutrition security and Soil Security, in line with a subset of the UN Sustainable Development Goals (Fig. 4).

Fig 4 ommited

2022 Michigan Negative
Disad things › DA – GMOs › Impact – Soil

GMOs alter the soil ecosystem – introduce foreign genes that effect species diversity and soil quality

Guan et al 16 – researcher in the Department of Life Sciences, Yuncheng University, Yuncheng, [Zheng-jun; Shun-bao, Luc; Yan-lin, Huo; Zheng-Ping, Guan, Biao Liu, WeiWei. “Do genetically modified plants affect adversely on soil microbial communities?” ScienceDirect. 3/15/16.]

Soil microorganisms play essential roles in agricultural production systems. With the increase in cultivation of various GM plants (e.g., insect-resistant or disease-resistant plants), soil microorganisms will be exposed to risks that may eventually adversely affect agricultural production systems. The introduction of foreign genes into GM plants may affect species diversity and amounts of root exudates, alter micro-ecological environments in the soil, and can strongly influence the soil ecosystem functions. Therefore, the core effect of growing GM plants on a soil is the change in soil ecosystem function, especially the effects on the related microbial communities. Some investigators believe that no inherent connection exists between the diversity and function, and the abundance of the species was found to not affect soil function substantially (Bardgett, 2002). There is no direct evidence showing that soil microbial diversity is related to soil ecosystem function. That is, a decrease in microbial diversity does not necessarily worsen soil ecosystem function, but the change in certain key species may matter (Tilman et al., 2001). On the other hand, Bender et al. (2016) synthesized the potential of soil organisms to enhance ecosystem service delivery and demonstrated that soil biodiversity promotes multiple ecosystem functions simultaneously (i.e., ecosystem multifunctionality). Current techniques and methods may not be effective enough to obtain the relevant evidence, or the available data may be inadequate to draw such conclusions. For example, soil ecosystem function may have correlations only with a few microbial species or show functional redundancy (Loreau et al., 2001). Nevertheless, the species abundance and diversity of soil microbes comprise an important reference parameter in the system of safety evaluation for GM plants and may represent a key element of the biosafety assessment of animal and plant diversity.

2022 Michigan Negative
Disad things › DA – GMOs › Impact – Soil

Extinction

Globe and Mail 7 John Allemang, feature writer, “Planet Earth has a dirty little secret”, May 12, Lexis Nexis

Dirt is disappearing, and when it goes, we go. It's a simple fact that we're using up our finite supply of good soil faster than it can be made, and whatever our eyes choose to tell us, a crisis is looming. Of course, like so much else about dirt, even its do-or-die crisis manages to be barely perceptible. In a world prepared to welcome the inconvenient truths of environmental degradation, and even make them the markers of intellectual fashion, poor old untrendy dirt somehow falls to the bottom of the global to-do list. Air pollution, water contamination, the limited lifespan of fossil fuels, the urgent need to confront climate change no matter how far away its worst threats may be - we get it, whatever don't-worry governments and vested interests like to pretend to the contraryBut erosion as the ultimate catastrophe, the dusty death blow? Somehow it's hard to feel apocalyptic about something you buy at a garden centre, scrape off your boots before walking through the door or scrub off your lettuce before the salad can be made."We take it for granted," agrees David R. Montgomery - which is a pretty hard admission for a man who has made it his goal to alert a distracted world to the crisis of lost soil.To his practised eyes, at least, the best part of the Earth is eroding and the danger signs are everywhere: bare plowed soil carried off by wind or rain, rivers choked by sediment from clear-cut forests, over-irrigated fields turned into salt-contaminated deserts, huge unprotected tracts of wheat or corn dependent on chemical fertilizer to replace the nutrients corporate agriculture discards, the constant stripping of topsoil to create new suburbias. Our complacency is so instinctive, our wastefulness so extreme, that Dr. Montgomery has come up with a disturbing new name for modern agriculture: soil mining."We only have a fixed amount of soil - and we're digging it up," he says.Dr. Montgomery is a geomorphologist at the University of Washington in Seattle, a well-travelled and well-read monitor of Earth's thin skin who knows that a civilization's lifespan depends on how it treats - or mistreats - its dirt. As a student of the Earth's eons of slow but certain transformations, he is trained to spot the big-picture inevitabilities the rest of us miss, and of this he is certain: "We're on track to lose most of our agricultural soils. And even if we solve the water crisis and the climate crisis, if we don't conserve soil, then that will do us in."You hear that, and you look around at the lushness of life in the spring, and the doomsday scenario seems unconvincing. Dirt is everywhere, the fields are full of crops, the supermarket shelves have their usual cornucopia look of gross overabundance and, if there's a famine in a far-off place, as there always is, can it really all come down to a few inches of topsoil that has gone missing?Yes is the short answer, according to Dr. Montgomery's wide-ranging new book, Dirt: The Erosion of Civilizations, which is to be published this week and has been deemed "a compelling manifesto" by New Scientist magazine. He takes pains to demonstrate the key role played by soil degradation in almost every civilization that once claimed to dominate the Earth - a useful antidote to the Golden Age nostalgia for a more harmonious past that afflicts many in the environmental movement. Wrecking soil, he implies, is something humans do, given the opportunity, because we're programmed to think of immediate issues such as personal survival rather than forgoing our inheritance to benefit the farmers of the future. And one reason we can do this with a clear conscience is our belief that soil is everywhere."People just don't realize that not all soils are good agricultural soils," Dr. Montgomery says. "And even with good soils, the pace at which it's being lost is slow by human standards even if it's quite rapid by geologic standards."You don't have to be a geologist to spot the problem. At least since the Dust Bowl crisis of the Depression era, when much of North America was blanketed by thick clouds of soil eroded off the drought-ridden prairie, soil specialists have put forward strong arguments for conservation - arguments that are all the more crucial since the western plains, as Dr. Montgomery observes, "are one of the few places on the planet that can produce agricultural surpluses and feed the world."In the Canadian West, a combination of high winds, heavy rains and years of drought has compromised the region's high-quality soil (a gift of the glacier action that collected and conveyed soil from the now-rocky Canadian North). To reduce erosion, soil advocates try to persuade farmers to cut down or even cut out the tilling (plowing) of the loose, granular soil, maintain grassy ground cover, practise crop rotation, reduce chemical fertilizer and pesticide use while making better use of manure, introduce windbreaks and work the land along more natural contours.As the price of oil has climbed, making it much more expensive to operate heavy farm machinery on a vast scale and spread fertilizer extravagantly, the more sustainable approach to agriculture is gaining converts in the West. No-till farming, in particular, has gone from being a wacky agrarian fantasy to being a widely accepted practice for those who want to maintain the industrial scale of agriculture while conserving the soil by disturbing it less. "Canada is leading the way on no-till," Dr. Montgomery says, approvingly.Concern about soil isn't confined to the wide-open wheat fields: In tiny Prince Edward Island, the potato industry faced bad publicity over the harmful effects of soil runoff, and a provincial act now mandates crop rotation (although critics point out that the government still permits a hefty annual erosion rate of three tons of soil per acre). The island's fine sandy loam has been identified as having huge potential for erosion due to the heavy summer rains that wash away exposed soil from vulnerable potato fields. Even to those who see dirt as inexhaustible, all that runoff is a problem: In a province where aquaculture is a major business as well as a way of life, pesticides and fertilizer nutrients from eroded soil quickly upset the delicate environmental balance.

2022 Michigan Negative
Disad things › DA – GMOs › Impact – Soil

GMOs destroy food security – increase pesticide dependence, proliferate ‘super-weeds’ and drain valuable resources

Soil Association 20 British baised charity organization that campaigns against intensive farming and emphasized local production [“Stop Genetic Modification.” The Soil Association. Nov 2020]

The GM industry has been promising for decades that genetically modified crops will revolutionise farming, and even solve world hunger. But none of their promises have come to fruition. There is little if anything to suggest the ‘next generation’ GM technology will be any different. Meanwhile, GM remains a distraction from the critical issues facing food and farming that can’t simply be solved by tweaking genes. What does GM really look like? Nearly all commercially released GM crops are produced by three chemical companies: Monsanto, Syngenta, and Bayer. Despite the pro-GM lobby’s promises that these products would lead to decreased pesticide use, the truth has proven to be quite the opposite: The use of Monsanto’s glyphosate-based weedkiller, Round-up, has skyrocketed since the introduction of glyphosate-resistant GM crops, becoming the most used weed-killer in the world. The blanket spraying of these weedkillers on GM crops is associated with environmental damage in North and South America, from degraded soils to the loss of food plants for wildlife such as the iconic Monarch butterfly. And these crops create herbicide-resistant ‘superweeds’, trapping farmers into an increasingly expensive arms race where the only winners are the chemical companies. There is also a long history of these GM crops contaminating other farms, which can be financially disastrous and poses a huge problem for organic farmers. At present, there are no commercial GM crops grown in the United Kingdom But we are still supporting these GM systems by importing them for much of our animal feed. If you buy: non-organic eggs, milk, yoghurt, cheese, meat or farmed fish from UK supermarkets, the chances are the animals behind those products were fed GM feed. We need a shift in priority to food security “GM is a huge distraction. It is diverting a massive amount of time, effort and attention from the really crucial issues facing food and farming - like looking after our soils. We have already degraded 25 to 40% of soils worldwide and unless we work very hard to reverse this damage, it will be impossible to feed the growing population healthily. GM is dangerous because it allows us to accelerate in the wrong direction for a short while longer.” Helen Browning, Soil Association Chief Executive We need to see a shift in priority to solving our underlying food problems. Techno-fixes like gene editing mustn’t distract from this. We need to: regenerate soils, diversify crops, use fewer chemicals, bring back wildlife and switch to foods that are better for us and the planet. This needs a dramatic shift towards farmer-led innovation and agroecology to create a climate and nature friendly future. Currently farmer-led research sees less than 1% of public research and development funding. Find out what our asks to the Government are around this and others here.

2022 Michigan Negative
Disad things › DA – GMOs › Impact - ABR

Antibiotic resistance causes mass death – cascading effects on treatment kill millions

Kwon and Powederly 21 –  assistant professor in the Division of Infectious Diseases in the Department of Medicine at the Washington University School of Medicine; professor in the Division of Infectious Diseases in the Department of Medicine at the Washington University School of Medicine [Jenny H., William G. “The post-antibiotic era is here.” Science, vol 373, issue 6554. 7/30/2021.]

Imagine a world where routine surgery or chemotherapy is considered too dangerous because there are no drugs to prevent or treat bacterial infections. Unless researchers develop new antibiotics and therapeutics, the decimation of modern medicine will soon become a reality. Scientists have long recognized that much stronger incentives for research and development are needed to avoid this scenario. Yet, the rise of “superbugs” has continued, making a pandemic of antibiotic resistance a major threat to global health. One could blame slowed action against antimicrobial resistance (AMR) on an upstaging by COVID-19. Health and industry sectors deferred prepandemic AMR work to focus on tracking and preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission. Worldwide, scientists pivoted toward SARS-CoV-2 research. This “all hands on deck” response was prudent but likely affected the already lagging progress on battling AMR. What about efforts before COVID-19? Prepandemic, experts noted that drug-resistant infections could, annually, kill 10 million people worldwide by 2050, and by 2030, AMR could force up to 24 million people into extreme poverty. Reports from the United Nations, the World Health Organization, and the UK and US governments promoted renewed public health and research programs, including targeted funding through the US National Institutes of Health and the Biomedical Advanced Research and Development Authority, to develop new drugs. Sadly, according to a March 2021 report by The Pew Charitable Trusts, there are only 43 new antibiotics in development. Of these, 13 are in phase 3 clinical trials, and only about half of these might be approved. It's no secret that the major problem is the lack of private-sector interest in bringing novel antimicrobial therapies through development. The war against AMR requires innovation, which is costly. It typically takes 10 to 15 years to develop an antibiotic through regulatory approval. According to the Pew report, among the 38 companies working on AMR, only two rank among the top 50 pharmaceutical companies (by sales). And only about one in four developments represents a novel drug class or a mechanism of action. We need new pharmaceutical targets to combat microbial virulence, new methods to inhibit the genetic transfer of antibiotic resistance between bacteria, new drugs that bolster host immunity against AMR, and microbiota-based therapies. To better track AMR, next-generation diagnostics are needed that use whole-genome and metagenomic sequencing and molecular techniques to detect AMR organisms in humans, animals, and the environment. Prior to 2020, the United States started paying attention to market-place incentives that would rekindle private investment. In 2013, the US Centers for Disease Control and Prevention (CDC) released its first Antibiotics Resistance Threats report, which prompted a National Action Plan for Combating Antibiotic-Resistant Bacteria in 2015. Fortunately, last October, the strategy was renewed for 5 years, directing federal agencies to spur new drug development. Also, the Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act was reintroduced in Congress last month. If the bipartisan bill passes, it will support a funding model that is not linked to sales, among other economic incentives. Although the White House's fiscal year 2022 budget plan leaves gaps in resources to address AMR, increases in health security budgets could be directed at incentivizing drug development. Given that the CDC's 2019 Antibiotic Resistance Threats report indicated that 2.8 million Americans acquire infections caused by AMR bacteria each year (with more than 35,000 resulting deaths), the government must do more to encourage private-sector interest. COVID-19 has shown that it is possible to create robust public-private partnerships across research, industry, and public health that accelerate research and clinical trials and spur proactive regulation in the context of a global public health threat. Collaborative action is equally necessary to battle AMR. The Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator, a global public-private partnership established in 2016, committed $500 million, through 2022, to support the development of new antibiotics and rapid diagnostics to tackle AMR. We need many more such creative partnerships. The scientific community should leverage lessons learned from COVID-19 to unite academia, industry, government, and policy-makers toward preserving the benefits of modern medicine. Continued procrastination will only lead to countless lives lost to AMR.

2022 Michigan Negative
Disad things › DA – GMOs › 2NC – Yes ABR

Greatest existential risk

O’Neil 16[Lord Jim O'Neill, the former chief economist for Goldman Sachs - the United Kingdom's commercial secretary to the Treasury and led the government's Review on Antimicrobial Resistance, Summer 2016, “The Global Threat of Antimicrobial Resistance”, Pew Trusts, , accessed 6-28-2022]

According to the World Health Organization (WHO), resistance to antibiotics and other types of antimicrobials is growing and represents the single greatest challenge in infectious diseases today. The WHO reported nearly half a million new cases of multidrug-resistant tuberculosis across 100 countries in 2013, amounting to more than 20 percent of previously treatable tuberculosis cases now being resistant to multiple drugs. In the United States, the Centers for Disease Control and Prevention estimates that each year, at least 2 million people become infected with bacteria that are resistant to antibiotics, and at least 23,000 of them die. This inflicts a direct cost of $20 billion on the U.S. health care system. In the agricultural sector, U.S. Food and Drug Administration sales data showed that drugmakers sold more than 20 million pounds of medically important antibiotics for use in food-producing animals in 2014—23 percent more than in 2009—the most ever reported and more than twice the amount of antibiotics sold to treat people.

This is a global health crisis that knows no borders. Left unchecked, antimicrobial resistance (AMR) will touch all people, regardless of their nationality or their country’s level of development. It will dangerously undermine health care as we know it, making common procedures such as cancer chemotherapy or cesarean section births—which depend on effective antibiotics to reduce their risks—far more dangerous than they are today. Indeed, by 2050, 10 million people a year could be dying as a result of AMR, up from around 700,000 today, with China and India each being home to about 1 million affected patients. And by then, an estimated $100 trillion in global GDP will have been lost.

2022 Michigan Negative
Disad things › DA – GMOs › 2NC – Yes ABR

Antibiotic Resistance bad for population, economy, and health care

Ventola 15 [C. Lee Ventola, Masters of Science, April 2015, “The Antibiotic Resistance Crisis. Part 1: Causes and Threats”, PubMed Central, , accessed 6-28-2022]

Antibiotic-resistant infections are a substantial health and economic burden to the U.S. health care system, as well as to patients and their families.1 They commonly occur in hospitals, due to the clustering of highly vulnerable patients, extensive use of invasive procedures, and high rates of antibiotic use in this setting.1 Nearly two million Americans per year develop HAIs, resulting in 99,000 deaths, most due to antibacterial-resistant pathogens.1 In 2006, two common HAIs (sepsis and pneumonia) were found to be responsible for the deaths of nearly 50,000 Americans and cost the U.S. health care system more than $8 billion.1

Antibiotic-resistant infections add considerable costs to the nation’s already overburdened health care system. When first-line and then second-line antibiotic treatment options are limited or unavailable, health care professionals may be forced to use antibiotics that are more toxic to the patient and frequently more expensive.5,11 Even when effective treatments exist, data show that in most cases patients with resistant infections require significantly longer hospital stays, more doctors visits, and lengthier recuperations and experience a higher incidence of long-term disability.5 The duration of hospital stays for patients with antibiotic-resistant infections was found to be prolonged by 6.4 to 12.7 days, collectively adding an extra eight million hospital days.1

2022 Michigan Negative
Disad things › DA – GMOs › 2NC – Yes ABR

Gmos cause antibacterial resistance

No Author 10 [“Genetically Modified Foods: The Consequences of Agricultural Design.”, Dartmouth Undergraduate Journal of Science, 3-21-2010, , accessed 6-29-2022]

Fear of gene transfer is also prominent in the debate surrounding GM foods. When making new genes, antibiotic resistance is coupled with the new genes since gene transfer is only successful in a few cells and a marker is needed to identify successful transfers. The antibiotic resistant cells are selected for further breeding and the resistance stays with the new gene and is incorporated into the crop. The fear of gene transfer comes from the potential of the genes from the GM foods to be taken up by bacteria in the gut during gestation (6). The fact that the new gene can and may interact with existing genes must be taken seriously. If bacteria carrying antibiotic resistance genes cause infection, they can be very difficult for doctors to treat (6). As a precautionary measure, some experts say that antibiotic resistance genes should not be used (6). A gene transfer could also result in the new gene deactivating an existing gene, with dramatic consequences for human health.

The environmental risks involved with GM crops are numerous. They include the GMO’s capability to escape and potentially introduce the engineered genes into wild populations, the persistence of the gene after the GMO has been harvested, the susceptibility of non-target organisms (e.g. insects which are not pests) to the gene product, the stability of the gene, the reduction in the spectrum of other plants including loss of biodiversity, and the increased use of chemicals in agriculture (3). The overall outstanding risk is the potential decrease in the biodiversity of crops and their associated insects and animals, shifting the forces of natural selection through direct human intervention. The arms race that now exists between natural species and the chemicals that we spray upon them hold the potential to give rise to newer super-species that we may one day lose control of.

2022 Michigan Negative
Disad things › DA – GMOs › 2NC – Yes ABR

Biotech cant solve Antibiotic resistance, kills millions

Bayer 22 [Max Bayer, staff writer for Fierce Biotech, 2-15-2022, “Biotech pipeline is outpaced by antibacterial resistance”, Fierce Biotech, , accessed 6-29-2022]

“The breadth and novelty of the antibacterial clinical-stage pipeline is insufficient to meet the ongoing threat of wide-spread infection from drug-resistant strains,” the report concluded.

Venture funding has lagged significantly for companies working on antibiotics compared to the larger biotech industry. Co-authors David Thomas and Chad Wessel, who lead the trade group’s industry research, found that from 2016-20, venture funding for antimicrobial ucompanies increased 29% compared to the five years prior, while funding for the biotech industry as a whole increased 175%.